Targeted radioiodine therapy of ovarian cancer via the sodium/iodide symporter (NIS) - Mielu LM; Rodal-Bravo L; Diego-Hernández C; Varona S; Fajardo-Delgado D; Hortiguela R; Torres-Ruiz M; Cuesta I; Pallares P; Santisteban P; García-Jiménez C; Martín-Duque P; et al. (Biomedicine & Pharmacotherapy, 2025)